Top Movers of the Day

Mover TrackerThursday, Jan 11, 2024 5:48 pm ET

1min read

Praxis Precision Medicines, Inc.'s (PRAX) stock price increased as the company announced the pricing of its $150 million public offering at $35.50 per share. Additionally, positive preliminary results were reported from PRAX-628 study in treating epilepsy patients, with full results expected in Q1 2024.

Comments

Post

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

You Can Understand News Better with AI.

Whats the News impact on stock market?

Its impact is

AInvest

Aime Coplilot

Invest Smarter With AI Power.

Open App